植德律师事务所

Represented an investment entity in multiple rounds of financing from Series B to Series E for a U.S. biotech company in Maryland specializing in the research and development of small nucleic acid drugs, as well as global acquisitions and restructuring before its listing ;
Represented an investment entity in multiple rounds of financing from Series A to Series B+ for a U.S. biotech company in Illinois specializing in the research and development of antibody-drug conjugates, as well as global acquisitions and restructuring ;
Represented a Chinese state-owned enterprise in dealing with a dispute over the control of a joint venture with a multinational industrial giant, triggered by the acquisition and restructuring of the global supply chain ;
Represented an investment entity in the acquisition and global demerger and restructuring of a leading Internet of Things company in California, including business demarcation, intellectual property division and cross-licensing, and capital structure restructuring ;
Represented a U.S. Nasdaq-listed company in achieving significant asset restructuring through the acquisition of domestic enterprises in China ;
Represented Chinese shareholders in the demerger and restructuring of a joint venture under a Fortune 500 mechanical manufacturing multinational company, selling Chinese stakes and associated enterprise assets;
Represented a state-owned enterprise in the acquisition of a real estate company in Yunnan;
Represented an investment entity in the merger and restructuring of two U.S. biotech companies in Illinois specializing in the research and development of metal nano-biomaterials through a stock-swap acquisition;
Represented an investment entity in parallel mirror investments in a company researching and developing orphan drugs for rare diseases targeting the norovirus, with operations in Kansas, USA, and Beijing, China;
Represented a company in Sichuan, China, and its overseas affiliates specializing in the research and development of deuterated drugs, in financing;
Represented a company in the British Virgin Islands in the indirect sale of real estate business in mainland China by selling shares of two companies in Hong Kong, China;
Represented a state-owned enterprise in the acquisition of a real estate company in Sichuan;
Represented a family trust from Jersey in convertible bond investment in an Australian real estate development company;
Represented an investment entity in investment and restructuring of a Chinese new energy smart automotive company;
Represented an investment entity in investment in a Chinese rocket manufacturing enterprise;
Represented a Chinese catering chain enterprise in strategic investment introduction, control transfer, and business integration;
Represented a listed company in the acquisition of a real estate company in Sichuan;
Represented an investment entity in the acquisition and industrial integration of a Sichuan automobile circulation and trading market;
Represented a real estate company in Sichuan in debt restructuring.